Prostatis Group’s iShares MSCI Emerging Markets ETF EEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-4,717
Closed -$201K 136
2024
Q2
$201K Buy
+4,717
New +$198K 0.07% 143
2023
Q1
Sell
-73,452
Closed -$2.78M 100
2022
Q4
$2.78M Buy
+73,452
New +$2.71M 1.7% 15
2022
Q2
Sell
-57,966
Closed -$2.62M 56
2022
Q1
$2.62M Buy
+57,966
New +$2.74M 2.1% 19
2021
Q2
Sell
-4,058
Closed -$216K 105
2021
Q1
$216K Sell
4,058
-39,529
-91% -$2.16M 0.17% 89
2020
Q4
$2.25M Buy
+43,587
New +$2.1M 1.89% 12

Other funds holding EEM

Prostatis Group's EEM Position: Q3 2024 in Review

Prostatis Group sold out of iShares MSCI Emerging Markets ETF (EEM) in Q3 2024, closing a stake of 4,717 shares — an estimated $201K sold.

Prostatis Group first reported a position in EEM in Q4 2020 and held it in 5 quarters. The position peaked at $2.78M in Q4 2022. 1,282 funds tracked by Wall St. Rank hold EEM as of Q3 2024.

  • Prostatis Group reported no remaining iShares MSCI Emerging Markets ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 4,717 iShares MSCI Emerging Markets ETF shares in Q3 2024, an estimated $201K.
  • Prostatis Group first reported a position in iShares MSCI Emerging Markets ETF in Q4 2020 and held it in 5 quarters.
  • Prostatis Group's iShares MSCI Emerging Markets ETF position peaked at $2.78M in Q4 2022.
  • 1,282 funds tracked by Wall St. Rank held iShares MSCI Emerging Markets ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.